TR201902547T4 - Oksi̇dati̇f stresli̇ hastalarda parati̇roi̇d hormonunun ölçüm araçlari ve yöntemleri̇ - Google Patents

Oksi̇dati̇f stresli̇ hastalarda parati̇roi̇d hormonunun ölçüm araçlari ve yöntemleri̇ Download PDF

Info

Publication number
TR201902547T4
TR201902547T4 TR2019/02547T TR201902547T TR201902547T4 TR 201902547 T4 TR201902547 T4 TR 201902547T4 TR 2019/02547 T TR2019/02547 T TR 2019/02547T TR 201902547 T TR201902547 T TR 201902547T TR 201902547 T4 TR201902547 T4 TR 201902547T4
Authority
TR
Turkey
Prior art keywords
methods
patients
oxidative stress
measurement tools
hormone
Prior art date
Application number
TR2019/02547T
Other languages
English (en)
Inventor
Paul Armbruster Franz
Hocher Berthold
Juergen Groen Hans
Juergen Roth Heinz
Original Assignee
Immundiagnostik Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immundiagnostik Ag filed Critical Immundiagnostik Ag
Publication of TR201902547T4 publication Critical patent/TR201902547T4/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/046—Thyroid disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7004—Stress
    • G01N2800/7009—Oxidative stress

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Buluş, vücut sıvısı numunelerindeki paratiroid hormonunun ölçüm araçları ve yöntemleri ile ilgilidir.
TR2019/02547T 2012-02-22 2013-02-22 Oksi̇dati̇f stresli̇ hastalarda parati̇roi̇d hormonunun ölçüm araçlari ve yöntemleri̇ TR201902547T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12156441.3A EP2631247A1 (en) 2012-02-22 2012-02-22 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress

Publications (1)

Publication Number Publication Date
TR201902547T4 true TR201902547T4 (tr) 2019-03-21

Family

ID=47845933

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/02547T TR201902547T4 (tr) 2012-02-22 2013-02-22 Oksi̇dati̇f stresli̇ hastalarda parati̇roi̇d hormonunun ölçüm araçlari ve yöntemleri̇

Country Status (8)

Country Link
US (1) US10317419B2 (tr)
EP (2) EP2631247A1 (tr)
JP (1) JP6178343B2 (tr)
CA (1) CA2865182C (tr)
ES (1) ES2716300T3 (tr)
PL (1) PL2817337T3 (tr)
TR (1) TR201902547T4 (tr)
WO (1) WO2013124462A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2775306B1 (en) * 2013-03-08 2018-06-27 Immundiagnostik AG Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients
AU2015220754A1 (en) 2014-02-20 2016-08-25 Immundiagnostik Ag In vitro diagnostic and prognosis of contrast induced nephropathy (CIN) in patients undergoing coronary angiography
EP3499235A1 (en) 2017-12-13 2019-06-19 Immundiagnostik AG Method of measuring auto-antibodies in bodily fluids
EP3740762A1 (en) 2018-01-17 2020-11-25 Immundiagnostik AG Biomarker predicting coronary artery disease
US20210404920A1 (en) 2018-08-20 2021-12-30 Immundiagnostik Ag Sorbent composition for pre-analytical treatment of samples

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3878231T2 (de) 1987-03-02 1993-05-27 Forssmann Wolf Georg Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
DE4434551A1 (de) 1994-09-28 1996-04-04 Forssmann Wolf Georg Prof Dr D Peptide aus der Sequenz des hPTH (1-37)
DE19961350A1 (de) 1999-12-17 2001-06-21 Immundiagnostik Ag Verfahren zur Bestimmung der Parathormon-Aktivität in einer menschlichen Probe
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
DE10116552A1 (de) * 2001-04-03 2002-10-10 Abc Armbruster Biochemicals Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
US20030082179A1 (en) 2001-07-03 2003-05-01 Hutchison James Scott Parathyroid hormone antibodies and related methods
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
US7959920B2 (en) * 2005-09-06 2011-06-14 Scantibodies Laboratory, Inc. Methods of making and using antibodies directed to parathyroid hormone

Also Published As

Publication number Publication date
WO2013124462A1 (en) 2013-08-29
EP2817337A1 (en) 2014-12-31
JP6178343B2 (ja) 2017-08-09
EP2631247A1 (en) 2013-08-28
JP2015513538A (ja) 2015-05-14
EP2817337B1 (en) 2018-12-19
US10317419B2 (en) 2019-06-11
PL2817337T3 (pl) 2019-06-28
CA2865182C (en) 2020-08-25
US20150017738A1 (en) 2015-01-15
ES2716300T3 (es) 2019-06-11
CA2865182A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
CL2015002562A1 (es) Anticuerpos e inmunoconjugados anti-b7-h4
CO7151531A2 (es) Anticuerpos e inmunoconjugados contra ly6e y métodos de uso
BR112017001579A2 (pt) anticorpos anti-cd3, anticorpos anti-cd3 ativáveis, anticorpos anti-cd3 multiespecíficos, anticorpos anti-cd3 ativáveis multiespecíficos e métodos de uso dos mesmos
SG11201601668PA (en) Assay test device, kit and method of using
EP3032250C0 (en) METHOD FOR MEASURING A SUBSTANCE AND MEASURING DEVICE WITH ELECTROCHEMICAL BIOSENSOR
WO2014107599A3 (en) Compositions and methods for detecting protease activity in biological systems
BR112014018136A2 (pt) anticorpos ou uso e método para determinar
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
BR112014029372A2 (pt) medição do corpo
EP2948895A4 (en) Pressure transient testing with sensitivity analysis
BR112015012192A2 (pt) dispositivo de medição de comprimento
MX2014014376A (es) Anticuerpos de anti-biotina y metodos de uso.
EP2988113A4 (en) DEVICE FOR MEASURING FLUID CONCENTRATION
BR112015009111A2 (pt) sensor de fluido, e, método para uso na fabricação do sensor de fluido.
EP3018464A4 (en) ADAPTER FOR BLOOD SAMPLING AS WELL AS DISPOSABLE SET AND NEEDLE SET THEREWITH
EP2991766A4 (en) Bodily fluid specimen collection and assay device
TR201902547T4 (tr) Oksi̇dati̇f stresli̇ hastalarda parati̇roi̇d hormonunun ölçüm araçlari ve yöntemleri̇
MX357675B (es) Anticuerpos anti-jagged y métodos de uso.
EP2986380C0 (en) SYSTEM FOR SAMPLING BIOLOGICAL LIQUIDS AND FOR SEPARATING AND TESTING BIOLOGICAL LIQUIDS
MX2014015088A (es) Anticuerpos anti-tofacitinib y usos de los mismos para monitorear farmacos.
MX2014014381A (es) Anticuerpos de anti-teofilina y metodos de uso.
BR112014006859A2 (pt) biossensor e seu dispositivo de medição
EP2990784A4 (en) LIQUID SAMPLE MEASURING DEVICE, LIQUID SAMPLE MEASURING METHOD, AND BIOSENSOR
GB201412156D0 (en) Analyte concentration measurement
GB201303168D0 (en) Immunoassay for detecting kratom, Its constituents and their use